Application of monoclonal antibody OC 125 in gynecological oncology. This study was undertaken to determine whether the measurement of CA125 could effect an early diagnosis and a method for monitoring the course of gynecologic tumors. CA 125 in serum of 195 patients, including 15 apparently healthy women 39 benign gynecologic tumors